K52-14982-02515
4 vaccinations
7 coded responses
32 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 550 / MN
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
JQD-26780-61299
Child or adolescent in my care · Female · 2022-06-29
PQA-23080-91650
Child or adolescent in my care · Male · 2022-06-29
XN5-84101-14506
Child or adolescent in my care · Female · 2022-12-21
Timeline
-
2021-03-10
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 2 — Pfizer-BioNTech
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
-
2021-06-30
Survey response — 3 months, dose 2MedDRA: Migraine with aura — Feeling: Good · Be unable to do your normal daily activitiesFree text: Increase in migraines with aurasMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-29
-
2021-11-08
Dose 3 — Moderna
- 2022-03-31
-
2022-05-09
Survey response — 6 months, dose 3MedDRA: Pre-eclampsia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Severe preeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-05-09
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-05-11
-
2022-05-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-21
Dose 4 — Moderna
- 2022-09-21
-
2022-09-22
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal painFree text: Axillary lymph node pain under arm where I got the injectionMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · HeadacheFree text: Swollen and painful axillary lymph node in arm where injection was givenMedDRA releases: 2024-11 · check-in free text available
-
2022-09-24
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · HeadacheFree text: Axillary lymph node pain and swelling on injection sideMedDRA releases: 2024-11 · check-in free text available
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
-
2022-11-02
Survey response — day 42, dose 4MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: FairFree text: Congestion and head coldMedDRA releases: 2024-11 · check-in free text available
- 2022-12-21
-
2023-03-22
Survey response — 6 months, dose 4MedDRA: Cholelithiasis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-03-22
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech | |
| 3 | 2021-11-08 | Moderna | No |
| 4 | 2022-09-21 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: Increase in migraines with auras
Release 11 — 6 months, dose 3
Symptoms: Severe preeclampsia
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Axillary lymph node pain under arm where I got the injection
Systemic reaction (other): Swollen and painful axillary lymph node in arm where injection was given
Systemic reaction (other): Axillary lymph node pain and swelling on injection side
Release 12 — day 42, dose 4
Symptoms: Congestion and head cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholelithiasis | · | · | ✓ |
| SD | Migraine with aura | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release